Veralox Therapeutics
Founded
2017
2017
Geography
United States of America based
United States of America based
Funding
$5.400 M
$5.400 M
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
Technologies
AI Companies (Drug Discovery)R&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet